Monoclonal antibody therapy for B-cell non-Hodgkin's lymphoma.
Cheson
Bruce D
BD
Division of Hematology-Oncology, Georgetown University Hospital, Washington, DC 20007, USA. bdc4@georgetown.edu
Leonard
John P
JP
D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20 / Q000276:immunology; D000954:Antigens, Surface; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001402:B-Lymphocytes / Q000276:immunology; D019008:Drug Resistance, Neoplasm; D006801:Humans; D007167:Immunotherapy; D016393:Lymphoma, B-Cell / Q000188:drug therapy* / Q000532:radiotherapy*; D016499:Radioimmunotherapy / Q000009:adverse effects; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D000954:Antigens, Surface; D000069283:Rituximab